Quantifying atherogenic lipoproteins for lipid-lowering strategies: consensus-based recommendations from EAS and EFLM.

• Langlois MR Department of Laboratory Medicine, AZ St-Jan, Ruddershove 10, 8000 Brugge, Belgium.
• Nordestgaard BG Herlev and Gentofte Hospital, Copenhagen University Hospital, University of Copenhagen, Copenhagen, Denmark.
• Langsted A Herlev and Gentofte Hospital, Copenhagen University Hospital, University of Copenhagen, Copenhagen, Denmark.
• Chapman MJ National Institute for Health and Medical Research (INSERM), Paris, France.
• Aakre KM Hormone Laboratory, Haukeland University Hospital, Bergen, Norway.
• Baum H Institute for Laboratory Medicine, Mikrobiologie und Blutdepot, Regionale Kliniken Holding RKH GmbH, Ludwigsburg, Germany.
• Borén J Institute of Medicine, Sahlgrenska Academy at Göteborg University, Gothenburg, Sweden.
• Bruckert E Department of Endocrinology and Prevention of Cardiovascular Disease, Pitié-Salpetriere University Hospital, Paris, France.
• Catapano A Department of Pharmacological and Biomolecular Sciences, University of Milan, Milan, Italy.
• Cobbaert C Department of Clinical Chemistry and Laboratory Medicine, Leiden University Medical Center, Leiden, The Netherlands.
• Collinson P Department of Clinical Blood Sciences, St George's University Hospitals NHS Foundation Trust and St George's University of London, London, UK.
• Descamps OS Department of Internal Medicine, Centres Hospitaliers Jolimont, Haine-Saint-Paul, Belgium.
• Duff CJ Department of Clinical Biochemistry, University Hospitals of North Midlands NHS Trust, Stoke-on-Trent, UK.
• von Eckardstein A Institute for Clinical Chemistry, University Hospital Zurich, Zurich, Switzerland.
• Hammerer-Lercher A Kantonspital Aarau AG, Institute for Laboratory Medicine, Aarau, Switzerland.
• Kamstrup PR Herlev and Gentofte Hospital, Copenhagen University Hospital, University of Copenhagen, Copenhagen, Denmark.
• Kolovou G Cardiology Department, Onassis Cardiac Surgery Center, Athens, Greece.
• Kronenberg F Department of Medical Genetics, Molecular and Clinical Pharmacology, Division of Genetic Epidemiology, Medical University of Innsbruck, Innsbruck, Austria.
• Mora S Division of Preventive Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
• Pulkki K Department of Clinical Chemistry, University of Turku and Turku University Hospital, Turku, Finland.
• Remaley AT Lipoprotein Metabolism Section, Cardiovascular-Pulmonary Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD, USA.
• Rifai N Boston Children's Hospital, Harvard Medical School, Boston, MA, USA.
• Ros E Lipid Clinic, Department of Endocrinology and Nutrition, Institut d'Investigacions Biomèdiques August Pi Sunyer, Hospital Clínic, Barcelona, Spain.
• Stankovic S Center for Medical Biochemistry, Clinical Center of Serbia, Belgrade, Serbia.
• Stavljenic-Rukavina A Libertas International University, Zagreb, Croatia.
• Sypniewska G Department of Laboratory Medicine, Collegium Medicum, NC University, Bydgoszcz, Poland.
• Watts GF Lipid Disorders Clinic, Department of Cardiology, Royal Perth Hospital, University of Western Australia, Perth, Australia.
• Wiklund O Institute of Medicine, Sahlgrenska Academy at Göteborg University, Gothenburg, Sweden.
• Laitinen P Department of Clinical Chemistry, HUSLAB, Helsinki University Hospital, Helsinki, Finland.

LDL cholesterol

apolipoprotein B

atherosclerotic cardiovascular disease

lipoprotein(a)

non-HDL cholesterol

remnant cholesterol